Objective：The conventional Papanicolaou smear seems to be more accurate for detecting a high-grade squamous intraepithelial lesion (HSIL) than a low-grade squamous intraepithelial lesion (LSIL). The purpose of this study was to investigate false-negative results of conventional Pap smear cytology in women with cervical conization. Methods：This study was performed in Gynecologic Oncology Clinic of the Department of Obstetrics and Gynecology at Dankook University Medical Center from July 1, 1994 to December 31, 2004. 260 women from age 22 to 75 years had undergone conventional Papanicolaou cervical cytologic test and cervical conization. Conization was performed using 'cold-knife cone' method or 'large electrosurgical excision procedure (LEEP) cone' method. The cervical cytology were studied in comparison with histology of conization specimens. Results：Of the 260 histologic diagnoses, there were 41 (15.8%) diagnoses of chronic cervicitis, 8 (3.1%) of CIN 1, 18 (6.9%) of CIN 2, 150 (57.7%) of CIN 3, 38 (14.6%) of SCC, 2 (0.8%) of AIS, 1 (0.4%) of ACC, and 2 (0.8%) of ASC. Pap cytology showed sensitivity of 97.9-98.2%, specificity of 4.9-6.7%, and false-negative rate of 1.8-2.2% according to the variables. Conclusion：Significantly false-negative rate of Pap cytology in women with conization was very low. And so, conventional Pap cytology is still clinically efficient for screening high-grade cervical lesions with adequate sampling technique.
INTRODUCTION
Cancer of the cervix uteri is the second most common cancer among women worldwide, with an estimated 493,000 new cases and 274,000 deaths in 2002. 1 Some 83% of the cases occur in developing countries, where cervical cancer accounts for 15% of female cancers, with a risk before age 65 of 1.5%, while in developed countries it accounts for only 3.6% of new cancers, with a cumulative risk (ages 0-64) of 0.8%. 1 The highest incidence rates are observed in sub-Saharan Africa, Melanesia, Latin America and the Caribbean, South Central Asia, and South East Asia. 2 Mortality rates are substantially lower than incidence. Worldwide, the ratio of mortality to incidence is 55%. Survival rates vary between regions. Because of cervical cancer affects relatively young women, it is an important cause of lost years of life in the developing world. 2 Yang et al. 3 found that it was responsible for 2.7 million (age-weighted) years of life lost worldwide in 2000 and it is the biggest single cause of years of life lost from cancer in developing world. But uniquely, cervical cancer re-mains eminently preventable. The key to prevention is the timely identification and management of precancerous lesions through accessible and affordable screening programs. 4 Traditional cervical screening methods are conventional Papanicolaou smear cytology and the pelvic examination. Since Dr. George Papanicolaou introduced this test for cervical cancer in 1939, the mortality rate for cervical squamous cell carcinoma in the United States decreased by 70-75% between 1955 and 1992. Today over 50 million tests are conducted annually in the United States. 5 But unfortunately, this method contains numerous inherent opportunities for error leading to an acceptably high false negative rate. Many researchers have reported a false negative rate from 6% to 55%. [6] [7] [8] [9] [10] In February 1999, a report from AHCPR (the Agency for Health Care Policy and Research) in the US admitted that estimates of the sensitivity of conventional Pap screening are not as high as previously reported. 16 The report mentioned that, based on the few studies that avoided severe biases, conventional Pap smear cytology showed sensitivity of 51% and specificity of 98%. Furthermore, the report stated that the conventional Pap test is more accurate when an high-grade squamous intraepithelial lesion (HSIL) threshold is used, with the goal of detecting a high-grade lesion, than when lower thresholds, such as a low-grade squamous intraepithelial lesion (LSIL) or ASCUS, are used, with the goal of detecting low or high-grade dysplasia. Conization of the cervix is both a diagnostic and therapeutic procedure and has the advantage over ablative therapies of providing tissue for further evaluation to rule out invasive cancer. Conization is indicated for diagnosis in women with HSIL based on a Pap test under the various conditions. 17 The purpose of this study was to investigate false-negative results of conventional Pap smear cytology in women with cervical conization in order to estimate diagnostic efficacy of conventional Pap smear cytology for detecting a high-grade lesion of the cervix.
MATERIALS AND METHODS

Study design
The study design was a retrospective, university hospital-based design in which the false-negative results of conventional Pap smear cytology were to be evaluated in women who received cervical conization. This study was performed in the Gynecologic Oncology Clinic of the Department of Obstetrics and Gynecology at Dankook University Medical Center from July 1, 1994 to December 31, 2004. Conventional Pap smear test was compared with a reference standard, the histologic diagnosis by conization biopsy. The main outcome measures are the rate of correspondence, sensitivity, specificity, and false-negative rate of Pap smear cytology relative to the histologic diagnosis.
260 women had undergone conventional Papanicolaou cervical cytologic test and cervical conization. Conization was indicated under the following conditions: 1) Limits of the lesion could not be visualized with colposcopy, 2) The squamocolumnar junction (SCJ) was not seen at colposcopy, 3) There was a lack of correlation between cytology, biopsy, and colposcopy results. 
Specimen collection for conventional Papanicolaou smear cytology
The cervical sample was taken in the usual way by the physician using a combination of plastic spatula and endocervical brush (cytobrush). Following collection according to the guidelines, the collection device was spread on the surface of the slide as evenly and thinly as possible (Fig. 1) . 18 Immediately the slide was fixed in 95% ethyl alcohol solution.
The slide and a case report form containing the patient's identification number, initials and medical history were sent to the pathology laboratory.
Papanicolaou cytology slide preparation and evaluation
The slides were prepared with the laboratory's routine Papanicolaou staining method, and evaluated according to The Bethesda System (TBS 1991 (TBS , 1994 (TBS , 2001 ) criteria. In brief, specimens that are not within normal limits can contain changes deemed either as benign cellular changes, or as cells that are consistent with an epithelial cell abnormality. The latter category includes precancerous cells that are consistent with low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) or squamous cell carcinoma (SCC), or cells that are atypical but cannot be categorized as intraepithelial lesion. These atypical cells are usually referred to by their acronyms, ASCUS (atypical squamous cells of undetermined significance) and AGUS (atypical glandular cells of undetermined significance). Pap slides were initially screened by cytotechnologists, and finally confirmed by a pathologist. False-negative cases were re-interpreted by a pathologist.
Conization
Conization was performed using 'cold-knife cone' method or 'large electrosurgical excision procedure (LEEP) cone' method after Schiller test at operating room. The biopsy specimen was fixed in 10% buffered formalin, paraffin embedded, and prepared as conventional histopathologic slides stained with hematoxylin and eosin. The biopsies were interpreted and diagnosed using a combined reporting system, including TBS and CIN (cervical intraepithelial neoplasia) designations by a pathologist.
Data analysis
The cytologic diagnoses of conventional Pap smear test were compared with the histologic diagnoses by conization. Comparisons were performed using standard cross-table analyses.
RESULTS
The 260 women had undergone conventional Papanicolaou cervical cytologic test and cervical conization. The mean age was 43.9 years (ranging from 22 to 75 years). The mean gravidity was 4.3 (from 0 to 18) and the mean parity was 2.5 (from 0 to 10). The mean number of abortion was 1.8 (from 0 to 12) and the mean number of living child was 2.4 (from 0 to 9).
On histology of the 260 cervical conization specimens, there were 41 (15.8%) cases of chronic cervicitis, 8 (3.1%) of CIN 1, 18 (6.9%) of CIN 2, 150 (57.7%) of CIN 3, 38 (14.6%) of SCC, 2 (0.8%) of AIS, 1 (0.4%) of ACC, and 2 (0.8%) of ASC in the histologic series.
On Pap cytology, there were 6 (2.3%) cases of negative, 40 (15.4%) of ASCUS, 24 (9.2%) of LSIL, 158 (60.8%) of HSIL, 29 (11.2%) of SCC, and 3 (1.2%) of AGUS (Table 1) . Table 1 showed correlation between cervical cytologic diagnoses and histologic diagnoses. Thirty eight histologic diagnoses of Table 2 showed false-negative results of cervical cytologic diagnoses especially in squamous cell abnormal lesions of the cervix. When ASCUS was included and benign lesion or glandular lesions (AGUS, AIS, ACC, and ASC) were excluded, there were 4 cases of false-negative diagnosis. False-negative rate showed 14.3% in CIN 1, 5.6% in CIN 2, 0.7% in CIN 3, and 2.6% in SCC. Overall false-negative rate was 1.9%. The cause of 4 false-negative cases revealed sampling errors. When ASCUS and benign lesion or glandular lesions (AGUS, AIS, ACC, and ASC) were excluded, there were 4 cases of false-negative diagnosis. False-negative rate showed 20.0% in CIN 1, 5.9% in CIN 2, 0.8% in CIN 3, and 2.9% in SCC. Overall false-negative rate was 2.2%.
DISCUSSION
Conization of the cervix plays an important role in the management of CIN. Before the availability of colposcopy, conization was the standard method of evaluating an abnormal Pap test result. Conization is both a diagnostic and therapeutic procedure and has the advantage over ablative therapies of providing tissue for further evaluation to rule out invasive cervical cancer. Conization is indicated for diagnosis in women with HSIL based on a Pap test under the various conditions. 17 The data of this study are consistent with results of other studies. 16 Also the report mentioned that although the effectiveness score for each threshold was relatively low, better discrimination was seen with higher cytological and histological threshold. Traditional cervical screening methods are pelvic examination and conventional Pap smear cytology. However, Pap smear cytology alone has the limitations of relatively low sensitivity and a high false negative rate. In February 1999, a report from AHCPR in the US admitted that estimates of the sensitivity of conventional Pap screening are not as high as previously reported. 16 Inherent drawbacks in Pap smear cytology can lead to inaccurate diagnoses of cervical lesions. Pap smear cytology is completely reliant upon exfoliated cell samples. Errors may occur in the process of sampling, preparation, and interpretation. Researchers have shown that sampling and preparation errors form the major contribution to the high false negative rate. While an average sample obtained during a Pap smear test will contain between 300,000 to 500,000 cells, abnormal cells may not be present on the slide in any case of the following: 1) the lesions don't exfoliate abnormal cells, 2) the exfoliated cells are trapped beneath a barrier, 3) the lesions exist in tissue below the surface where they are unavailable for exfoliation, 4) the abnormal cells may simply be missed by the collecting device, or 5) the collecting device retrieves an accurate sampling but it may transfer only normal cells to the slide. 21 Some researchers reported that more than 80% of the cell sample is thrown away with the sampling device into the trash at the doctor's office, and that the remaining sample on the slide may not necessarily represent the condition of the cervix. Sherman et al 22 Squamous cancer of the cervix accounts for approximately 80-85% of invasive cervical cancer cases. Adenocarcinoma, which accounts for another 10-15%, may be increasing in incidence. Cervical cytology may also be less sensitive for adenocarcinoma. Therefore cervical cancer prevention requires eradication of pre-cancerous lesion known as CIN. Liquid-based cytology seems to be superior to conventional Pap cytology because of sample adequacy for detecting pre-cancerous lesions of the cervix. The central purpose of cervical cancer screening is the detection and management of high-grade lesions, particularly CIN 3 (severe dysplasia and carcinoma in situ). The data in this study revealed that false-negative rate of the squamous cell abnormalities showed 5.6% (1/18) in CIN 2, 0.7% (1/150) in CIN 3, and 2.6% (1/38) in SCC. Overall false-negative rate in high-grade lesions (CIN 2 or worse) showed 1.5% (3/206) ( Table 2 ). The results of this study indicate that false-negative rate of Pap cytology in women with conization was significantly very low. And so, these data are thought to confirm the accuracy of the conventional Pap cytology for diagnosing high-grade cervical lesions as well as liquid-based cytology.
Because of inherent drawbacks in Pap smear cytology, many kinds of ancillary or adjunctive tests including liquid-based cytology for cervical cancer screening were developed in order to increase the sensitivity and decrease the false-negative rate 4, 18 In-vivo adjunctive tests assess the cervix directly.
Visual tests such as colposcopy, speculoscopy, and cervicography evaluate the cervix for the presence of identifiable abnormalities, and are not dependent on exfoliation. In these tests diseased areas of the cervix, including areas of dysplasia, have larger nuclei than normal cervical cells. As a result, they have a higher N/C (nuclear：cytoplasmic) ratio. These cells will not allow light to pass through as well as normal cells do, and the underlying vascular layer is not seen. Thus the absence of color or whitening is seen, while the normal tissue appears pink. Pap smear cytology and visual tests are sensitive to different properties of cervical lesions, and so these two tests are theoretically additive from the viewpoint of cellular pathophysiology. 21 Soler and Blumenthal 4 reported three current trends toward improving cervical cancer screening: the first is to improve the test qualities of cytology-based screening (liquid-based cytology and computerized analysis of Papanicolaou test), the second is to improve the test qualities through various combinations of parallel or sequential tests, and the third is the possibility to make use of advances in digital and spectroscopic techniques. 4, 18 The data from this study demonstrate that false-negative rate of Pap cytology in women with conization was very low. And so, conventional Pap cytology is still clinically efficient for screening high-grade cervical lesions with adequate sampling technique.
